Plain-English translation of NCT06127004 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Metacognitive Training for Negative Symptoms (MCT Minus) — a specialized psychological program designed to help people with schizophrenia who struggle with negative symptoms like social withdrawal, lack of motivation, and reduced emotional expression. The program works by helping you understand and change thinking patterns that may be keeping these symptoms in place. You'll work one-on-one with a trained therapist for eight sessions.
Many people with schizophrenia experience negative symptoms that are hard to treat with medication alone, and these symptoms are often what bothers patients the most. Researchers believe that the way people think about themselves and their future may be fueling these symptoms, so this treatment targets those thought patterns directly.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll attend eight individual sessions with a trained therapist who will teach you thinking skills and strategies to help with withdrawal, motivation, and emotional expression. The sessions are delivered one-on-one (rather than in a group) so they can be tailored to your needs. You'll be compared to a control group receiving supportive counseling to see which approach works better.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Sweden